Finance

Beta
Ask
Lists
MLAB:NASDAQ
Mesa Laboratories Inc
$95.48
+0.56%
(+0.54) 1D
Jun 18, 1:11:33 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MLAB...
Open
$95.68
High
$97.80
Low
$94.14
Mkt. cap
527.55M
Avg. vol.
214.20K
Volume
77.72K
Dividend
0.67%
Quarterly dividend
$0.16
Ex-dividend date
May 29, 2026
P/E ratio
79.17
52-wk high
$113.99
52-wk low
$55.54
EPS
$1.21
Beta
0.94
Shares outstanding
5.52M
No. of employees
717
Open
$95.68
High
$97.80
Low
$94.14
Mkt. cap
527.55M
Avg. vol.
214.20K
Volume
77.72K
Dividend
0.67%
Quarterly dividend
$0.16
Ex-dividend date
May 29, 2026
P/E ratio
79.17
52-wk high
$113.99
52-wk low
$55.54
EPS
$1.21
Beta
0.94
Shares outstanding
5.52M
No. of employees
717
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to MLAB in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for MLAB in the last 3 months.
Highest
Current $95.48
$94.00 (-1.56%)
Average
$94.00 (-1.56%)
Lowest
$94.00 (-1.56%)
News stories
From sources across the web
About Mesa Laboratories Inc
CEO-
Employees717
Founded1982
HeadquartersLakewood, Colorado, United States
SectorHealth care
Last report
May 27, 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
$1.83 / $1.39
+31.47%beat
Revenue / Est. (USD)
63.72M / 65.20M
-2.26%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
59.54M
60.74M
65.13M
63.72M
Cost of goods sold
22.60M
23.41M
23.33M
21.52M
Cost of revenue
22.60M
23.41M
23.33M
21.52M
Research and development expenses
4.98M
5.05M
5.03M
5.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28.89M
27.56M
28.79M
34.21M
Operating expense
33.88M
32.61M
33.82M
39.46M
Total operating expenses
56.48M
56.01M
57.15M
60.98M
Operating income
3.06M
4.72M
7.98M
2.75M
Other non operating income
6.15M
137.00K
-
4.06M
EBT including unusual items
7.01M
2.00M
4.60M
-1.59M
EBT excluding unusual items
7.01M
2.00M
4.60M
-1.59M
Income tax expense
2.27M
-477.00K
966.00K
2.54M
Effective tax rate
32.37%
-23.86%
21.02%
-159.64%
Other operating expenses
-
-
-
-
Net income
4.74M
2.48M
3.63M
-4.14M
Net profit margin
7.96%
4.08%
5.57%
-6.49%
Earnings per share
1.88
2.11
1.76
1.83
Interest and investment income
-
-
-
-
Interest expense
-2.20M
-2.86M
-3.04M
-2.60M
Net interest expenses
-2.20M
-2.86M
-3.04M
-2.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
9.02M
10.57M
13.69M
8.50M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more